MSB 5.24% $1.11 mesoblast limited

Cell Therapy News/Articles, page-23

  1. 6,118 Posts.
    lightbulb Created with Sketch. 1053
    The point is many question the effectiveness of MSB products and other companies for that matter. However, major pharmas who have their drugs on the market with disclaimer side effects and are not necessarily a full treatment in many cases and costing the government BILLIONS are now under scrutiny especially for their pricing.

    Things are changing and some things take years to work out but the damage is already done to the economy and in many cases to people's stomachs, levers etc.

    The point is it needs to change at some point and cell therapy will be bigger than people think.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.11
Change
0.055(5.24%)
Mkt cap ! $1.261B
Open High Low Value Volume
$1.05 $1.13 $1.04 $6.781M 6.207M

Buyers (Bids)

No. Vol. Price($)
3 43856 $1.11
 

Sellers (Offers)

Price($) Vol. No.
$1.11 66000 1
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.